Lifeboat Foundation

Dr. Matthew O’Connor from the SENS Research Foundation gives a fascinating talk about this years successful results of the mitochondrial repair project (MitoSENS) and the potential for repairing age-related damage to the mitochondria that SENS proposes. 2017 could be an even better year for progress, please consider donating to the SRF Winter Fundraiser and help them make age-related disease a thing of the past.

Please take a few minutes to watch SENS Research Foundation’s Matthew O’Connor give a Google TechTalk during Google’s Giving Week campaign. The topic is his recently published article on our MitoSENS Research. If you enjoy this presentation and support our work please go to our website and donate today. Your support is critical to our success. You can donate at www.sens.org/donate

Continue reading “Rejuvenating the Mitochondria” »

The team showed that a new form of gene therapy produced a remarkable rejuvenating effect in mice. After six weeks of treatment, the animals looked younger, had straighter spines and better cardiovascular health, healed quicker when injured, and lived 30% longer.

Juan Carlos Izpisua Belmonte, who led the work at the Salk Institute in La Jolla, California, said: “Our study shows that ageing may not have to proceed in one single direction. With careful modulation, ageing might be reversed.”

Continue reading “Ageing process may be reversible, scientists claim” »

Excellent article by Nick Gillespie, Editor-in Chief of Reason. Genetic editing is so far the 21st Century’s most important science—and it’s already being challenged by many as too radical: http://reason.com/blog/2016/12/15/will-gene-editing-technologies-spark-the #transhumanism #CRISPR #Future

The folks behind CRISPR gene editing were runners-up for Time’s Person of the Year. Their creation may win the future for secular China.

Continue reading “Will Gene-Editing Technologies Spark the Next Cold War? They Already Have” »

It is looking increasingly likely the mysterious Google Calico have very modest ambitions regarding increased lifespans for humans given the comments made by Dr. Aubrey de Grey and others and the direction they are taking with their research. Modest increases of lifespan over the kind of robust therapies of SENS seems pretty dissapointing.

More about Google Calico and their aim to modestly increase lifespan. People like Dr. Aubrey de Grey and Nathaniel David from rising biotech star Unity.

“To some, Calico’s heavy bet on basic biology is a wrong turn. The company is “my biggest disappointment right now,” says Aubrey de Grey, an influential proponent of attempts to intervene in the aging process and chief science officer of the SENS Research Foundation, a charity an hour’s drive from Calico that promotes rejuvenation technology. It is being driven, he complains, “by the assumption that we still do not understand aging well enough to have a chance to develop therapies.” Indeed, some competitors are far more aggressive in pursuing interventions than Calico is.

Continue reading “Can naked mole rats teach us the secrets to living far longer? Google thinks so” »

Babies made from two women and one man have been approved by the UK’s fertility regulator.

The historic and controversial move is to prevent children being born with deadly genetic diseases.

Doctors in Newcastle — who developed the advanced form of IVF — are expected to be the first to offer the procedure and have already appealed for donor eggs.

Continue reading “Babies made from three people approved in UK” »

Researchers at the University of Minnesota have achieved a “major breakthrough” that allows people to control a robotic arm in three dimensions, using only their minds. The research has the potential to help millions of people who are paralyzed or have neurodegenerative diseases.

Continue reading “How to control a robotic arm with your mind — no implanted electrodes required” »

IBM Watson is known for its work in identifying cancer treatments and beating contestants on Jeopardy! But now the computing system has expertise in a new area of research: neuroscience.

Watson discovered five genes linked to ALS, sometimes called Lou Gehrig’s disease, IBM announced on Wednesday. The tech company worked with researchers at the Barrow Neurological Institute in Phoenix, Arizona. The discovery is Watson’s first in any type of neuroscience, and suggests that Watson could make discoveries in research of other neurological diseases.

SEE ALSO: This high-tech E.L.F. is guiding confused shoppers with the help of IBM’s Watson.

Sometimes a drug intended for one purpose turns out to have other uses. Metformin, a treatment for type 2 diabetes, may prove effective in treating cancer.

Researchers are a step closer to figuring out how metformin may help prevent cancer.

Metformin is generally used to treat type 2 diabetes. The drug helps the body use insulin more effectively.

Continue reading “Inexpensive Diabetes Drug May Be New Weapon in War on Cancer” »

Senescent cell removal holds great potential but are all research approaches equal?

Some scientific commentary on senescent cell clearing (Senolytics) and the different approaches the research community is engaged in.

“Researchers are taking two broad approaches to cellular senescence at the present time. The first is to build therapies that can selectively destroy senescent cells, following the SENS rejuvenation model of periodic removal of damage. If the number of senescent cells is managed so as to keep that count low, then they will not cause further harm. This has the advantage of being straightforward and requiring little further research to put into practice. A range of demonstrated treatments and potential treatments already exist — gene therapies, immunotherapies, senolytic drugs, and so forth — and companies such as Oisin Biotechnologies and UNITY Biotechnology are bringing some of these technologies to the clinic.”

Continue reading “Can Cellular Senescence be Reversed in the Near Future, and is Reversal Desirable?” »